Scarica l'app Stockscreener
11.67
0.43%
0.05
Dopo l'orario di chiusura:
11.91
0.24
+2.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$11.62
Aprire:
$11.6
Volume 24 ore:
102.76K
Relative Volume:
1.09
Capitalizzazione di mercato:
$130.48M
Reddito:
$346.10M
Utile/perdita netta:
$-20.02M
Rapporto P/E:
-6.4022
EPS:
-1.8228
Flusso di cassa netto:
$-1.47M
1 W Prestazione:
+1.39%
1M Prestazione:
-3.07%
6M Prestazione:
+9.78%
1 anno Prestazione:
-11.99%
Intervallo 1D:
$11.51
$11.79
Intervallo di 1 settimana:
$11.38
$11.79
Portata 52W:
$9.22
$13.60
Medifast Inc Stock (MED) Company Profile
Nome
Medifast Inc
Settore
Industria
Telefono
(410) 581-8042
Indirizzo
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, HRB, FTDR, BFAM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
11.67 | 130.48M | 346.10M | -20.02M | -1.47M | -1.8228 |
ROL
Rollins Inc
|
32.15 | 15.47B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
77.83 | 10.61B | 4.33B | 535.79M | 486.05M | 3.79 |
HRB
H R Block Inc
|
43.83 | 5.37B | 3.91B | 736.10M | 760.88M | 5.6238 |
FTDR
Frontdoor Inc
|
77.83 | 5.36B | 2.12B | 260.00M | 385.00M | 3.5067 |
BFAM
Bright Horizons Family Solutions Inc
|
68.17 | 3.32B | 2.98B | 189.18M | 275.20M | 3.3254 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-05 | Aggiornamento | DA Davidson | Underperform → Neutral |
| 2024-06-05 | Downgrade | DA Davidson | Neutral → Underperform |
| 2023-10-13 | Iniziato | Stephens | Equal-Weight |
| 2022-11-04 | Downgrade | DA Davidson | Buy → Neutral |
| 2022-08-04 | Downgrade | Jefferies | Buy → Hold |
| 2021-01-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-11-05 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2020-06-25 | Iniziato | B. Riley FBR | Buy |
| 2020-02-27 | Downgrade | Jefferies | Buy → Hold |
| 2019-11-08 | Downgrade | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | Iniziato | Jefferies | Buy |
| 2018-11-08 | Aggiornamento | Sidoti | Neutral → Buy |
| 2018-03-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2017-09-15 | Reiterato | DA Davidson | Buy |
| 2016-08-04 | Reiterato | Wunderlich | Hold |
| 2016-01-11 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-11-30 | Downgrade | Sidoti | Buy → Neutral |
| 2015-10-05 | Aggiornamento | Sidoti | Neutral → Buy |
| 2014-11-07 | Downgrade | Imperial Capital | Outperform → In-line |
| 2014-08-08 | Reiterato | Imperial Capital | Outperform |
| 2014-04-23 | Reiterato | Imperial Capital | Outperform |
| 2013-09-06 | Iniziato | Imperial Capital | Outperform |
| 2012-11-06 | Reiterato | Northland Securities | Outperform |
| 2012-07-27 | Aggiornamento | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | Downgrade | Standpoint Research | Buy → Hold |
| 2012-01-30 | Iniziato | Standpoint Research | Buy |
Mostra tutto
Medifast Inc Borsa (MED) Ultime notizie
Can Hormel Foods Keep Expanding Margins Despite Softer Retail Volumes? - Zacks Investment Research
Medifast presented Trilivy data and Medifast stock costs EUR 10.16 - AD HOC NEWS
Can Hormel Foods Tackle Input Costs With Pricing and Efficiency? - Zacks Investment Research
Medifast stock faces a smaller coach base after Q2 revenue beat - AD HOC NEWS
Can Medifast's Better Client Retention Support Revenue Stabilization? - Zacks Investment Research
Can Medifast's Better Client Retention Support Revenue Stabilization? - Yahoo Finance
Can Medifast's Better Client Retention Support Revenue Stabilization? - TradingView
Why Do You Keep Gaining Weight Back After Losing It - GlobeNewswire Inc.
Bank of America buys 87,118 Medifast shares for its portfolio - AD HOC NEWS
Medifast stock gets a new Bank of America stake - AD HOC NEWS
Bank of America Corp DE Purchases New Holdings in Medifast Inc $MED - marketbeat.com
Medifast director trust sells 19,089 shares. Medifast stock gains 1.67 percent - AD HOC NEWS
Don't Ignore The Insider Selling In Medifast - Simply Wall Street
Will Innovation and Digital Expansion Efforts Drive Clorox's Growth? - Zacks Investment Research
Here's Why Shares of BranchOut Food Surge 89% in a Year - Zacks Investment Research
Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,544 Shares - MarketBeat
Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,545 Shares - MarketBeat
Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com South Africa
Medifast director Daniel Chard sells $226,288 in company shares - Investing.com
Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com Canada
A preset trading plan covers Medifast (MED) director Chard's trust sales of 9,545 and 9,544 shares. - Stock Titan
Medifast (MED) officer Daniel Chard proposes selling 9,544 shares after a sale of 9,545 shares - Stock Titan
Hormel Foods Pricing Strategy: Can It Balance Value and Profitability? - Zacks Investment Research
Four stock-award lots make up Medifast (MED) officer Daniel Chard’s planned sale of 9,545 shares. - Stock Titan
Medifast, Inc. (MED) Stock Price, News, Quote & History - Yahoo! Finance Canada
Medifast, Inc. (MED) stock price, news, quote and history - Yahoo Finance Australia
Medifast (NYSE:MED) Stock Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Medifast stock gains as revenue reaches USD 76.38 million - AD HOC NEWS
Medifast stock holds near 52-week low as revenue outlook weakens - AD HOC NEWS
Medifast stock edges lower as guidance and analyst views diverge - AD HOC NEWS
MEDIFAST INC Q2 2026 Earnings: Loss Narrower Than Expected, Stock Edges HigherEarnings Manipulation Risk - careplusvn.com
BlackRock Inc. Makes New Investment in Medifast Inc $MED - MarketBeat
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Eastern Progress
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates - Eastern Progress
Medifast (NYSE:MED) Stock Crosses Above 200 Day Moving AverageTime to Sell? - marketbeat.com
Premiumization and Strong Brands Fuel Constellation Brands' Growth - Zacks Investment Research
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - Eastern Progress
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - Yahoo Finance
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report? - Yahoo Finance
MEDIFAST INC (MED) Peer Comparison – Compare with Others - valueresearchonline.com
Medifast Launches the Medifast Metabolic Health Institute - directsellingnews.com
MEDIFAST INC (MED) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Medifast director Kiai Parsa buys $529k in MED stock By Investing.com - Investing.com Nigeria
Medifast director Kiai Parsa buys $529k in MED stock By Investing.com - Investing.com Canada
Medifast (NYSE: MED) director adds 43K shares in open-market buy - stocktitan.net
MEDIFAST INC (MED) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Medifast (NYSE:MED) Director Purchases 43,150 Shares - marketbeat.com
After 45 years of research, Medifast launches a metabolic health institute - stocktitan.net
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™ - Yahoo Finance
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health? - Yahoo Finance
Medifast Inc Azioni (MED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Medifast Inc Azioni (MED) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chard Daniel R | Officer |
Sep 29 '26 |
Proposed Sale |
11.73 |
9,544 |
111,951 |
0 |
| Chard Daniel R | Director |
Sep 29 '26 |
Sale |
11.73 |
9,544 |
111,951 |
130,609 |
| Chard Daniel R | Officer |
Sep 28 '26 |
Proposed Sale |
11.98 |
9,545 |
114,338 |
0 |
| Kiai Parsa | Director |
Aug 26 '26 |
Buy |
12.26 |
43,150 |
529,157 |
707,492 |
| Kiai Parsa | Director |
Aug 24 '26 |
Buy |
12.00 |
4,329 |
51,946 |
665,517 |
| Kiai Parsa | Director |
Aug 20 '26 |
Buy |
11.60 |
43,150 |
500,700 |
661,306 |
| Kiai Parsa | Director |
Aug 19 '26 |
Buy |
11.66 |
29,337 |
341,999 |
619,331 |
| SCHLACKMAN SCOTT | Director |
May 11 '26 |
Buy |
12.53 |
2,500 |
31,325 |
30,549 |
| SCHLACKMAN SCOTT | Director |
May 08 '26 |
Buy |
12.65 |
2,500 |
31,625 |
28,049 |
| Chard Daniel R | Chairman & CEO |
Mar 20 '26 |
Buy |
10.11 |
17,678 |
178,725 |
17,678 |
2.09%
38.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):